The purification and properties of the second component of human complement
- 1 April 1978
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 171 (1) , 99-107
- https://doi.org/10.1042/bj1710099
Abstract
The second component of human complement (C2) was purified by a combination of euglobulin precipitation, ion-exchange chromatography, (NH4)2SO4 precipitation and affinity chromatography. The final product was homogeneous by the criterion of polyacrylamide-gel electrophoresis and represents a purification of about 4000-fold from serum with 15-20% yield. Component C2 comprises a single carbohydrate-containing polypeptide chain, with an apparent mol.wt. of 102000; alanine is the N-terminal amino acid. The molecule is rapidly cleaved by activated subcomponent C1s with the loss of haemolytic activity to yield two fragments with apparent mol.wts. of 74000 and 34000. These fragments are not linked by disulphide bonds and can be easily separated. A second protein isolated during the purification of component C2 was identified by its haemolytic and antigenic properties as complement Factor B, the protein serving an analogous function to component C2 in the alternative pathway. The protein, which is also a single carbohydrate-containing polypeptide chain, has an apparent mol.wt. of 95000 and threonine as N-terminal amino acid. The amino acid analyses of component C2 and Factor B are compared.This publication has 28 references indexed in Scilit:
- Glycoprotein staining following electrophoresis on acrylamide gelsPublished by Elsevier ,2004
- The isolation and structure of C4, the fourth component of human complementBiochemical Journal, 1977
- Structural heterogeneity of C2 Complement protein and its genetic variants in man: a new polymorphism of the HLA region.Proceedings of the National Academy of Sciences, 1977
- Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf.The Journal of Experimental Medicine, 1976
- Inherited deficiency of the second component of complement. Rheumatic disease associations.Journal of Clinical Investigation, 1976
- The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement PathwaysScandinavian Journal of Immunology, 1976
- The unactivated form of the first component of human complement, C1Biochemical Journal, 1976
- The Alternative Pathway of Complement ActivationPublished by Elsevier ,1976
- DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*Annals of the New York Academy of Sciences, 1964
- THE OXIDATION OF RIBONUCLEASE WITH PERFORMIC ACIDJournal of Biological Chemistry, 1956